Nizhny Novgorod-Maryland Biotechnology Partnership
description
Transcript of Nizhny Novgorod-Maryland Biotechnology Partnership
Nizhny Novgorod-MarylandBiotechnology Partnership
September 10-11, 2013
Maryland-Russia Collaborations
Baltimore’s deepwater port
Rail: AmTrak corridor
Air: BWI, Washington-Dulles & Reagan International
UNSURPASSEDBUSINESS ACCESS:100 mi.
200 mi.
400 mi.
300 mi.
500 mi.
600 mi.
Same day or overnight access to 1/3 of U.S. industry, markets,
and populationJust two hour access to 80% of the U.S.
pharmaceutical industry and more than 2,000 biotechnology companies
CONNECTED GLOBALLY and REGIONALLY
MARYLAND
Road: Multi interstate 95
Judy Britz, Ph.D., Executive DirectorBioMaryland Center
From Research to Reality to Revenues
The Government as a Catalyst of Innovation and Growth: the Case for BioMaryland 2020
Governor O’Malley committed to
$1.3 Billion Investment/10 Years
BioMaryland 2020
Maryland Biotechnology Industry
Biomanufacturing
Agriculture/Food
Bioinformatics
Genomics
Therapeutics
Proteomics
Diagnostics BioDefense EnvironmentDevices
Dmitri Mendeleev• Chemist• Periodic Chart• 1st Vodka Standards• Founded 1st Oil Refinery
• Increase access to capital• Connect entrepreneurs with resources• Grow jobs in the BIO industry• Assist translation of research to products• Other
– Provide Business Plan Feedback – Identify Partners, Collaborators and Clients – Match Training and Workforce
> 500 BioCompanies- Focus: 50% Biotherapeutics- 25% Medical Devices/Diagnostics- 25% CROs/Research Tools
> 34,000 Employees- Average Salary: $91,100
> $10 Billion in Revenues
JCVI
USAMRIIDUSAMRMC
NIBC, NBACC, NCI
UMCPVMRCVM
ECBC
UMB-SOM, IHV
GTU
GWU
USUHS
WRAIR
JHU
FDA CVM
USDA
NIHMDA
MD DBED
UMDNIST
BARCFDA CFSAN
UMBC
UMCES
UMD-ACES
FDAJHU APL
• National Institutes of Health (NIH)• Food and Drug Administration (FDA)• Center for Medicare and Medicaid Services (CMS)• Center for Excellence in Regulatory Science (CERSI)• Food Safety and Inspection Service (FSIS)• Federal Labs: BioDefense and Human Health• Johns Hopkins University • University of Maryland System
Maryland’s Unique Assets
Maryland Center for Excellence in Regulatory Science and Innovation
$1.1 B Acquisition
Universities Companies
MD STEM Cell Research Fund
MD Innovation Initiative (MII)
Phase II Phase IIIPhase I
Basic Research Translational Research Product Development
Technology Validation Program
Patent Assistance Program
Tech. Commercialization Fund
Angel Affinity Funds
Maryland Industrial Partnerships (MIPS)
Translational Research Award Biotechnology Commercialization Award
Biotechnology Tax Credit
MD Venture Fund
Cybersecurity Tax Credit
Research and Development Tax Credit
TEDCO
USM
MBC
DBED
KEY:
• BioMaryland Award Programs: $7M• Maryland Innovation Initiative: 10.8M• Biotechnology Tax Credits: $48M• InvestMaryland: $84M next 3yrs• Stem Cell Funding: ~$100M• R&D Tax Credit: >$30M
Cumulative Investment
BioMaryland Center’s Biotechnology Development Awards Program
• Applicants have tripled from since inception• Two main Categories: Translational Research
and Commercialization Awards• >$7.0M Awarded to >30 Companies and 3
University projects
Maryland Innovation Initiative
• Purpose: Commercialization of University Research/IP
• Participating: Hopkins, University of Maryland (UMBC, UMB, UMCP),Morgan State
• 2012: $5.8M First Year Funding• 2013: $5M Followon• Companies who have licensed University Research
eligible• Administered by TEDCO
BioMaryland LIFE Prize
• Collaborative Prize with Johns Hopkins and University of Maryland
• Annual Alliance Meeting• 100+ Angels, VCs, Pharma, Entrepreneurs• Two $50,000 Competitive Awards
– Abell Foundation added $100,000 to pool
DBED’s Biotechnology Investor Tax Credit
• Model Program for Nation for Angel Investors• 2013: Increase from $8M to $10M• $48M in credits deployed to >60 companies
– >$90 leveraged in investment• Goal: $24M by 2020
DBED’s Invest Maryland VC Program• 2011- InvestMaryland Legislation passed• 2012 - $84 M Raised in Tax Credit Auction
– $28M+ Maryland Venture Fund– $56M Private Venture Capital
• First Bioinvestments– Brainscope AdLyfe– Theranostics Plasmonix– PathSensors
InvestMaryland Challenge
• Statewide Business Plan Competition• $425K in Prizes• Over 200 Applications received
– Life Science – Maryland Only (55 Companies)– Cyber/IT – Maryland Only– General – Outside Maryland
Leveraged financing from the private sector Direct financing (Loans, Contract Financing) Loan Guarantees & Credit Enhancement Tax Exempt and Taxable-Revenue Bonds Tax Credits (Job Creation, Enterprise Zone) Export Assistance Other State Resources: TEDCO, MIPs (University) Federal Sources: SBIR/STTR
Other Sources of Capital
FREE Access to Market Research Resources
BioMed Tracker • Frost & Sullivan • Deloitte Recap • MedTrack
San Diego June 23-26, 2014
www.Bio.Maryland.gov
United States
Canada
India
United Kingdom
China
France
RussiaGermany
South Korea
Philippines
Ireland
Spain
Puerto Rico
SwitzerlandJapan
Egypt
Netherlands
Taiwan
Turkey
Indonesia
Mexico
Brazil
Malaysia
Italy
Ukraine
Australia
Hong King
Israel
Singapore
Argentin
a
Poland
Finland
Paki
stan
Columbia
Vietnam
Bulgaria
Belgium Swed
en
South Africa
Nigeria
ThailandU.A.E.
Czech Republic
IranSaudi Arabia
Norway
Chil
e
Portugal
Ghana
New Zealand
Peru
Mongolia
Kenya
Sri Lanka
Cameroon
Costa Rica
Dominican Republic
Ecuador
Ethiopia
Jamaica
Morocco
Bolivia
Guatemala
Iraq
Uruguay
Venezuela
Kazakhstan
Tanzania
SudanU.S. Virgin Islands
Panama
Barbados
Bermuda
The Bahamas
Côte d'Ivoire
CubaAlgeria
Guam
Mauritius
Uganda
British Virgin Islands
Yemen
Iceland
Maldives Papua New Guinea
Angola
Libya
Namibia Somali
a
From Research to Reality to Revenues
Спасибо !